A curious divergence is unfolding for Palantir Technologies. The data analytics firm recently posted quarterly results that surpassed Wall Street’s forecasts, yet its share price has faced significant pressure. This contradiction highlights a central debate among investors: to what extent has the company’s future growth already been factored into its current market valuation?
Quarterly Results Outpace Expectations
On February 2, Palantir released its fourth-quarter financials, delivering a robust performance. The company reported earnings per share (EPS) of $0.25, exceeding the consensus estimate of $0.23. Revenue climbed to $1.41 billion, also beating analyst projections of $1.34 billion. This top-line figure represents a substantial 70% increase compared to the same period last year.
Despite these operational successes, the market reaction was decidedly negative. In the 30-day period following the report, the stock declined by 25.6%, underscoring a disconnect between financial performance and investor sentiment.
Key Financial Highlights from the Q4 Report:
* Revenue: $1.41 billion (Estimate: $1.34 billion)
* Earnings Per Share (EPS): $0.25 (Estimate: $0.23)
* Year-over-Year Revenue Growth: +70%
The Valuation Debate Intensifies
The stock’s retreat has refocused attention on Palantir’s rich valuation. Analyst commentary in the wake of the report revealed a split in market opinion. HSBC upgraded its rating to “Buy” and raised its price target to $205, citing powerful momentum within the company’s commercial business segment.
Should investors sell immediately? Or is it worth buying Palantir?
In contrast, DA Davidson maintained a “Neutral” stance but lowered its price target from $215 to $180. The core issue, as noted in research, is Palantir’s price-to-earnings (P/E) multiple, which stands above 220. At such an elevated level, there is minimal room for operational missteps. Consequently, even strong quarterly numbers may not propel the share price higher if they fail to exceed already sky-high expectations. Paying for “perfection” makes the market particularly sensitive to any deviation from an aggressive growth trajectory.
Institutional Moves and Insider Activity
Shifts in holdings by major investors and transactions by company insiders have also drawn scrutiny. Recent regulatory filings present a mixed picture:
- Norges Bank substantially increased its position in Q2 2025, expanding its holding by 34.9%. The stake was valued at approximately $3.3 billion following this move.
- Vanguard grew its position by 4.0% in Q3 2025, bringing its total holdings to over 205 million shares.
- Flagship Harbor Advisors reduced its exposure in more recent reporting periods by roughly 22%.
Insider activity has leaned toward selling. In the 90 days leading up to early February, corporate insiders disposed of approximately 1.02 million shares. Later transactions in 2025 included sales by CEO Alexander Karp and other executives totaling more than $167 million.
Amidst these flows, a fundamental strength remains: the company’s balance sheet is described as robust. Palantir reported carrying zero debt for the 2026 fiscal year.
Looking ahead, the critical test will be whether Palantir can sustain its high growth rate in coming quarters. With its ambitious valuation, the focus is less on whether the company will grow, but rather on how powerfully that growth continues.
Ad
Palantir Stock: Buy or Sell?! New Palantir Analysis from February 5 delivers the answer:
The latest Palantir figures speak for themselves: Urgent action needed for Palantir investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 5.
Palantir: Buy or sell? Read more here...
